For Immediate Release
Contact:
John M. Martino
Phone Number: (215) 895-1186
Date: 04/18/02
New
Drugs Marketed in 2001 May Be Small in Number, But Not
in Importance
--
A University of the Sciences in Philadelphia Health
Tip --
There
were a total of 26 therapeutic agents that reached the
United States market for the first time in 2001.
This marked the smallest number of new therapeutic
agents to hit the U.S. market since 1995, when only
23 new medications were unveiled in the states.
According to Dr. Daniel Hussar, Remington professor
of pharmacy at Philadelphia College of Pharmacy at University
of the Sciences in Philadelphia, there may have been
a decrease in the number of newer medications released
to Americans, but some of them have significant advantages
over older medications.
"The
new medications have a wider range of uses," says Dr.
Hussar, "and a number of them have mechanisms of action
or other characteristics that distinguish them from
previously marketed drugs."
Here
is a list of the new drugs marketed in 2001:
|
Generic
Name
|
Trade
Name
|
Manufacturer
|
Therapeutic
Classification
|
|
Alemtuzumab
|
Campath
|
Berlex
|
Antineoplastic
agent
|
|
Almotriptan
malate
|
Axert
|
Pharmacia
|
Agent for
migraine
|
|
Anakinra
|
Kineret
|
Amgen
|
Antiarthritic
agent
|
|
Balsalazide
sodium
|
Colazal
|
Salix
|
Agent for
ulcerative colitis
|
|
Bimatoprost
|
Lumigan
|
Allergan
|
Agent for
glaucoma
|
|
Bivalirudin
|
Angiomax
|
The
Medicines Company
|
Anticoagulant
|
|
Bosentan
|
Tracleer
|
Actelion
|
Agent for
pulmonary arterial hypertension
|
|
Botulinum
toxin type B
|
Myobloc
|
Elan
|
Agent for
cervical dystonia
|
|
Caspofungin
acetate
|
Cancidas
|
Merck
|
Antifungal
agent
|
|
Cefditoren
pivoxil
|
Spectracef
|
TAP |
Antibiotic |
|
Cetrorelix acetate
|
Cetrotide |
Serono
|
Agent for
infertility
|
|
Darbepoetin
alfa
|
Aranesp
|
Amgen
|
Agent for
anemia
|
|
Drospirenone/
ethinyl estradiol
|
Yasmin
|
Berlex
|
Contraceptive
|
|
Drotrecogin
alfa (activated)
|
Xigris
|
Lilly
|
Agent for
sepsis
|
|
Formoterol
fumarate |
Foradil
|
Novartis
|
Antiasthmatic
agent |
|
Galantamine
hydrobromide
|
Reminyl
|
Janssen
|
Agent
for Alzheimer's disease |
|
Imatinib mesylate
|
Gleevec |
Novartis |
Antineoplastic agent
|
|
Insulin
aspart |
NovoLog
|
Novo
Nordisk |
Antidiabetic
agent |
|
Insulin
glargine |
Lantus
|
Aventis
|
Antidiabetic
agent
|
|
Nateglinide
|
Starlix
|
Novartis
|
Antidiabetic
agent
|
|
Nesiritide
|
Natrecor
|
Scios
|
Agent
for congestive heart failure
|
|
Peginterferon
alfa-2b
|
PEG-Intron
|
Schering
|
Antiviral
agent
|
|
Tenofovir
disoproxil
fumarate
|
Viread
|
Gilead
Sciences
|
Antiviral
agent |
|
Travoprost
|
Travatan
|
Alcon
|
Agent
for glaucoma
|
|
Ziprasidone
hydrochloride
|
Geodon
|
Pfizer
|
Antipsychotic
agent
|
|
Zoledronic
acid
|
Zometa
|
Novartis
|
Agent for
hypercalcemia of malignanc
|
Dr.
Hussar says these new therapeutic agents may be confusing
to the general public, adding that individuals should
consult their local pharmacist.
"Pharmacists have the most comprehensive knowledge
of medications on the market," says Dr. Hussar.
"Pharmacists understand the properties of these
new therapeutic agents and can effectively counsel
patients about their use and serve as a valuable source
of information for other health professionals regarding
these drugs."
To
arrange an interview with Dr. Hussar, contact John
Martino at (215) 895-1186 or email: j.martin@usip.edu.
###
|
